Genmab — Maj 2016
-
shareholders the ability to act at any time to replace directors.
Medivation has declined to engage in sale talks with Sanofi unless the latter raises its $52.50 per share cash offer first, sources have said. The French drugmaker has said it is willing to raise its bid only after Medivation engages with it in negotiations. (Full Story)
Medivation shares ended trading on Tuesday in New York at $61.91. -
Medivation has signed non-disclosure agreements to share confidential information with other pharmaceutical companies interested in an acquisition, including Pfizer Inc PFE.N and Amgen Inc AMGN.O, sources told Reuters earlier this month. (Full Story)
-
Carnegie er bull: http://play.borsen.dk/social/57448490725ed7540a0d572c
-
Da det så er Chicago tid, så skal lægge 7 timer til.
-
Anoyme er stadig sulten efter frokost. Nordea har forspist sig.
-
Lad dem endelig slå mave resten af dagen.
-
Det må være oksekødet som fylder meget i maven med alle de bullcerifikater som de har slugt i dag.
-
1217...Stærkt comeback.
-
Jeg har et afkast på 89,59% på genmab og blev anbefalet at lave et stop loss på kurs 1125. Hvad siger du Helge eller andre til det?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind